In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Quest to buy AmeriPath for $1.23bn

Executive Summary

Quest Diagnostics has agreed to buy cancer testing and diagnostic services company AmeriPath for $1.23bn in cash. (Private equity firm Welsh, Carson, Anderson, and Stowe took over control of AmeriPath in 2003 for $650mm.) It will also assume $770mm of the company's debt, bringing the total value of the deal to about $2bn.
Deal Industry
  • In Vitro Diagnostics
  • Services
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies